Radium
Research stageAlso known as Xofigo.
Recent clinical, regulatory, research and industry developments relating to this drug.
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes6
Journals, researchers & institutions
- Annals of oncology : official journal of the European Society for Medical Oncology1
- Cancer immunology research1
- Allaire KM1
- Bhatt RS1
- Bompas E1
- Bubley GJ1
- Chen BK1
- Cheung A1
- Choudhury A1
- Choudhury AD1
- Beth-Israel Deaconess Medical Center1
- Broad Institute of Harvard and MIT1
- Centre Hospitalier de l'Université de Montréal1
- City of Hope Comprehensive Cancer Center1
- Cliniques Universitaires Saint Luc1
- Dana-Farber Cancer Institute1
Related diseases
Regulator-approved indications and conditions co-mentioned with this drug across the research literature. Number shows shared papers.
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
Studied across 2 of the same disease areas as Radium in the shared literature.
Studied across 2 of the same disease areas as Radium in the shared literature.
Studied across 2 of the same disease areas as Radium in the shared literature.
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature